{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T16:47:48Z","timestamp":1751561268527,"version":"3.40.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.urolonc.2024.01.035","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T20:28:35Z","timestamp":1711225715000},"page":"175.e19-175.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort"],"prefix":"10.1016","volume":"42","author":[{"given":"Nicholas James","family":"Corsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Finati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Malchow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chase","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keinnan","family":"Hares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohrab","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Ottone","family":"Cirulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1298-8231","authenticated-orcid":false,"given":"Firas","family":"Abdollah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.01.035_bib0001","first-page":"275","article-title":"New standard for localized UTUC","volume":"17","author":"Killock","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"10232","key":"10.1016\/j.urolonc.2024.01.035_bib0002","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2024.01.035_bib0003","unstructured":"Roupr\u00eat M, Gontero P, Birtle A, Comp\u00e9rat EM, Dominguez-Escrig JL, Liedberg F, et al. Upper urinary tract urothelial cell carcinoma - Disease Management - Uroweb. EAU Guidelines on Upper Urinary Tract Urothelial Carcinoma. 1\u201344."},{"key":"10.1016\/j.urolonc.2024.01.035_bib0004","doi-asserted-by":"crossref","unstructured":"Flaig T, Spiess P, Abern M, Agarwal N, Bangs R. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology, Bladder Cancer, Upper GU Tract Tumors, version 2.2022. 2022;20:866\u201378.","DOI":"10.6004\/jnccn.2022.0041"},{"key":"10.1016\/j.urolonc.2024.01.035_bib0005","unstructured":"American College of Surgeons and the American Cancer Society. About the National Cancer Database | ACS."},{"key":"10.1016\/j.urolonc.2024.01.035_bib0006","unstructured":"Commission on Cancer. Facility Oncology Registry Data Standards: National Cancer Database. Accessed January 15, 2024. National Cancer Database (NCDB) | ACS (facs.org)"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.035_bib0007","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/1467-9469.00072","article-title":"Multiple Hypotheses Testing with Weights","volume":"24","author":"Benjamini","year":"1997","journal-title":"Scand J Stat"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.035_bib0008","doi-asserted-by":"crossref","DOI":"10.2202\/1557-4679.1103","article-title":"Exact calculations of average power for the Benjamini-Hochberg procedure","volume":"4","author":"Glueck","year":"2008","journal-title":"Int. J. Biostat."},{"key":"10.1016\/j.urolonc.2024.01.035_bib0009","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(20)30519-5","article-title":"Treatment of upper urinary tract urothelial carcinoma","volume":"395","author":"Crabb","year":"2020","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.urolonc.2024.01.035_bib0010","first-page":"S10512","article-title":"Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change","volume":"100","author":"Herrera","year":"2010","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.035_bib0011","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.semradonc.2019.05.005","article-title":"National cancer database: the past, present, and future of the cancer registry and its efforts to improve the quality of cancer care","volume":"29","author":"McCabe","year":"2019","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.035_bib0012","first-page":"607","article-title":"Trends of incidence and prognosis of upper tract urothelial carcinoma","volume":"21","author":"Wu","year":"2021","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.urolonc.2024.01.035_bib0013","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Re: Alison Birtle, Mark Johnson, John Chester, et al. Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial","volume":"395","author":"Singla","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.035_bib0014","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.urolonc.2010.07.016","article-title":"The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC)","volume":"31","author":"Audenet","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.035_bib0015","unstructured":"Upper Urinary Tract Urothelial Cell Carcinoma - DISEASE MANAGEMENT - Uroweb."},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.035_bib0016","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1464-410X.1998.00800.x","article-title":"The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract","volume":"82","author":"Miyake","year":"1998","journal-title":"Br J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.035_bib0017","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.eururo.2020.04.006","article-title":"Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial","volume":"78","author":"Afferi","year":"2020","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.035_bib0018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eururo.2020.08.015","article-title":"Re: adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT Trial): a phase 3, open-label, randomised controlled trial","volume":"79","author":"D'Andrea","year":"2021","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2024.01.035_bib0019","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.69.4141","article-title":"Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma","volume":"35","author":"Seisen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.035_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11701-007-0049-3","article-title":"Robotic urology in the United Kingdom: experience and overview of roboticassisted cystectomy","volume":"1","author":"Elhage","year":"2008","journal-title":"J Robot Surg"},{"key":"10.1016\/j.urolonc.2024.01.035_bib0021","unstructured":"Office For National Statistics: Census 2021. Population estimates by ethnic group and religion, England and Wales - Office for National Statistics. 2018."},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.035_bib0022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/bju.14039","article-title":"Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer","volume":"121","author":"Abdollah","year":"2018","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.035_bib0023","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.urolonc.2009.11.005","article-title":"Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview","volume":"30","author":"Scosyrev","year":"2012","journal-title":"Urol Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T02:25:56Z","timestamp":1714011956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1078143924000516"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.035","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}